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Interaction of Gramicidin S and its Aromatic Amino-Acid Analog
with Phospholipid Membranes
Masoud Jelokhani-Niaraki,* Robert S. Hodges,y Joseph E. Meissner,* Una E. Hassenstein,*
and Laura Wheaton*
*Department of Chemistry, Wilfrid Laurier University, Waterloo, Ontario, Canada; and yDepartment of Biochemistry and Molecular Genetics,
University of Colorado Denver, School of Medicine, Anschutz Medical Campus, Aurora, Colorado

ABSTRACT To investigate the mechanism of interaction of gramicidin S-like antimicrobial peptides with biological membranes, a series of ﬁve decameric cyclic cationic b-sheet-b-turn peptides with all possible combinations of aromatic D-amino
acids, Cyclo(Val-Lys-Leu-D-Ar1-Pro-Val-Lys-Leu-D-Ar2-Pro) (Ar [ Phe, Tyr, Trp), were synthesized. Conformations of these
cyclic peptides were comparable in aqueous solutions and lipid vesicles. Isothermal titration calorimetry measurements
revealed entropy-driven binding of cyclic peptides to POPC and POPE/POPG lipid vesicles. Binding of peptides to both vesicle
systems was endothermic—exceptions were peptides containing the Trp-Trp and Tyr-Trp pairs with exothermic binding to
POPC vesicles. Application of one- and two-site binding (partitioning) models to binding isotherms of exothermic and
endothermic binding processes, respectively, resulted in determination of peptide-lipid membrane binding constants (Kb). The
Kb1 and Kb2 values for endothermic two-step binding processes corresponded to high and low binding afﬁnities (Kb1 $ 100 Kb2).
Conformational change of cyclic peptides in transferring from buffer to lipid bilayer surfaces was estimated using ﬂuorescence
resonance energy transfer between the Tyr-Trp pair in one of the peptide constructs. The cyclic peptide conformation expands
upon adsorption on lipid bilayer surface and interacts more deeply with the outer monolayer causing bilayer deformation, which
may lead to formation of nonspeciﬁc transient peptide-lipid porelike zones causing membrane lysis.

INTRODUCTION
Interaction of antimicrobial peptides with cell membranes has
been considered as a fundamental, if not the only, step in the
mechanism of their antimicrobial activity (1,2). It has been
known that helical cationic peptide antibiotics interact with
cell membranes of both prokaryotic and eukaryotic cells, alter
or destroy the cell membrane integrity, and cause lysis leading
to the cell death (3,4). In comparison to the linear helixforming cationic antimicrobial peptides, the mechanism of
interaction of cyclic cationic antimicrobial peptides (CCAPs)
with biological membranes is much less understood (5). To
investigate the mechanism of interaction of small CCAPs with
biological model membranes, we have designed and synthesized a series of amphipathic decameric b-sheet-b-turn cyclic
peptides with different combinations of aromatic D-aminoacid (phenylalanine, tyrosine, and tryptophan) substitutions.
The prototypic models for the peptides of this study are the
naturally found decameric CCAPs, gramicidin S (GS), and
tyrocidines of the same bacterial origin (6,7).
Gramicidin S, the principal prototype for the peptides
of this study, is a CCAP from the Gram-positive bacteria
Bacillus brevis that has been widely utilized as a topical
antibiotic (8). The backbone structure of GS is comprised of a
double-stranded antiparallel b-sheet connected by a pair
of type II9 b-turns on both ends (Fig. 1) (9–11). GS is active
against a broad range of both Gram-positive and Gram-nega-

tive bacteria as well as fungi, but is also highly hemolytic
against mammalian erythrocytes (12). The physicochemical
properties, synthetic procedures, and biological activity of GS
and tyrocidines, as well as hundreds of their different analogs, have been investigated in detail (6,7,13).
The sequences of GS and its ﬁve analogs are shown in
Table 1. The peptides share two type II9 b-turns composed of
four amino acids (-Leu-D-Xxx-Pro-Val-, where Xxx is an
aromatic amino acid) on the two ends of an antiparallel
b-sheet, stabilized by four backbone intramolecular hydrogen
bonds. In addition to sharing the b-sheet-b-turn conformation, the peptides of Table 1 are also amphipathic. The hydrophobic residues (Val and Leu) in these peptide molecules
are located on one face and Lys (Orn in the case of GS) residues are located on the opposite face. A typical structure and
orientation of the amino-acid residues of the peptides of Table
1 are depicted in Fig. 1, a representation of the three-dimensional structure of GS supported by molecular modeling.
In this study, we have utilized the biophysical techniques,
circular dichroism (CD), ﬂuorescence spectroscopy, and
isothermal titration calorimetry (ITC), to explore the conformation and modes of interaction of aromatic b-sheet-bturn amphipathic CCAPs with model biological membranes
and suggested a model for the mechanism of interaction of
these peptides with lipid membranes.
MATERIALS AND METHODS
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Chemicals
Gramicidin S was purchased from Sigma (St. Louis, MO) and further puriﬁed
by RP-HPLC. All other peptides were synthesized by solid-phase procedures
doi: 10.1529/biophysj.108.137471
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assay (12,14). The reported values for both antimicrobial and hemolytic
assays were determined after 24 h at 37°C.

Large unilamellar vesicles for spectroscopic and
ITC experiments

FIGURE 1 Molecular model for the amphipathic b-sheet-b-turn conformation of GS.
using tert-butyloxycarbonyl (Boc) chemistry. N-[(1H-benzotriazol-1yl)
(dimethylamino)methylene]-n-methylmethanaminium hexaﬂuorophosphate
n-oxide (HBTU) and 1-hydroxybenzotriazole (HOBT) were used to activate
C-terminus of the amino acids. Lys side chains were protected by formyl
groups throughout the syntheses. After cleavage from resin and puriﬁcation
by RP-HPLC, linear peptides were cyclized in a head-to-tail manner (Pro
at the C-terminus) utilizing benzotriazole-1-yl-oxy-tris-(dimethylamino)phosphonium hexaﬂuorophosphate (BOP), 1-hydroxybenzotriazole, and n,
n-diisopropylethylamine in n,n-dimethylformamide, and Lys residues of the
cyclized peptides were then deprotected in dilute methanolic HCl at 40°C (12,14).
Peptides were puriﬁed and analyzed by RP-HPLC, and their ﬁnal purity was
further conﬁrmed by electrospray mass spectrometry (Table 1). Concentration of
the pure peptides in aqueous stock solutions was determined by amino-acid
analysis (65% error). Phospholipids, 1-palmitoyl-2-oleoyol-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyol-sn-glycero-3-phosphoethanolamine
(POPE), and 1-palmitoyl-2-oleoyol-sn-glycero-3-[phosphor-rac-1-glycerol]
(sodium salt) (POPG) were from Avanti Polar Lipids (Alabaster, AL). Stock
lipid solutions were in chloroform. All other chemicals were of reagent grade
and used as received without further puriﬁcation.

Antimicrobial and hemolytic activity assays
Microbial strains were prepared as described previously (12,14). The peptide
activity against microorganisms was measured by a liquid broth assay
method (12). Staphylococcus aureus (SAP0017 and K147), Staphylococcus
epidermidis, Bacillus subtilis, Enterococcus faecalis, and the coryneform
bacteria Corynebacterium xerosis were the Gram-positive bacterial strains.
Gram-negative bacterial strains were Pseudomonas aeruginosa (K799 and
Z61), Escherichia coli (UB1005 and DC2), and Salmonella typhimurium
(C587 (14028S) and C610 (MS4252S)). The yeast strain employed was
Candida albicans. Freshly collected human blood cells were prepared as
described, and hemolytic measurements were performed in a liquid-based

Chloroform solutions of the lipids POPC and POPE/POPG (7/3 molar ratio)
were dried, under a mild nitrogen ﬂush, in a round-bottomed ﬂask to form a
thin ﬁlm. The ﬁlm was further dried overnight under reduced pressure. The
dried lipid ﬁlm was then hydrated with buffer at room temperature. The resulted multilamellar vesicles were then freeze-thawed a few times and extruded through a 100-nm ﬁlter in a LiposoFast apparatus (Avestin, Ottawa,
Canada) (15). The prepared large unilamellar vesicles (average diameter of
;80 nm) were stable in dark for several days at 4°C.
Two phospholipid vesicle systems were utilized for this study. The ﬁrst
system contained POPC lipid bilayers, which can be considered as a model
for the mammalian blood cell membranes. The second system contained
POPE and POPG phospholipids ([phosphatidylethanolamine (PE)]/[phosphatidylglycerol (PG)] ¼ 7/3) to model the negatively-charged bacterial
membranes. Similar to biological membranes, the two lipid bilayer systems
used for the biophysical measurements in this study were in the liquid
crystalline state.

Instrumentation
Peptides were analyzed on a Waters 600E HPLC system (Waters, Franklin,
MA) using a Waters C4 Symmetry (150 3 4.6 mm I.D., 5 mm particle size,
30 nm pore size) at 25°C. CD spectra were measured on an Aviv 215
spectropolarimeter (Aviv Biomedical, Lakewood, NJ). Ellipticities are
reported as mean residue ellipticity, [u]. Spectra were measured in buffer
solutions composed of ﬁnal concentrations of Tris(hydroxymethyl)aminomethane hydrochloride (Tris) (10 mM), NaF (100 mM), at pH 7.4, unless
speciﬁed otherwise. The measurements were in quartz cells with 0.1 or 0.05
cm pathlengths, at 25°C. Sodium ﬂuoride was used in buffer to reduce the
high noise levels of chloride ions at wavelengths at ,200 nm.
Fluorescence spectra were measured on a Cary Eclipse ﬂuorescence
spectrophotometer (Varian, Palo Alto, CA), using quartz cells of 1 cm
pathlength. The slit-widths for both excitation and emission wavelengths
were 5 nm. Spectra were measured at 25°C in buffer solutions composed of
ﬁnal concentrations of Tris (10 mM), NaCl (100 mM), at pH 7.4; 80%
methanol; and 0.5–1 mM POPC lipid dispersions in Tris (10 mM), NaCl (100
mM) buffer, at pH 7.4.
ITC measurements were performed on a VP-ITC microcalorimeter (MicroCal, Northampton, MA) at 30°C. All solutions were degassed under reduced pressure for at least 5 min before use. The calorimeter was calibrated
electronically. In all experiments, phospholipids (5 mM lipid concentration)

TABLE 1 Peptide sequences, their molecular mass, retention time, and relative hydrophobicity (see legend for deﬁnitions)
Peptide

Sequence

GS10WW
GS10FW
GS
GS10WY
GS10FY
GS10YY

Cyclo-(VKLdWPVKLdWP)
Cyclo-(VKLdFPVKLdWP)
Cyclo-(VOLdFPVOLdFP)
Cyclo-(VKLdWPVKLdYP)
Cyclo-(VKLdFPVKLdYP)
Cyclo-(VKLdYPVKLdYP)

MW (Da): c/m
1246.76
1207.74
1140.69
1223.70
1184.72
1200.74

/
/
/
/
/
/

1247.03
1207.69
1140.77
1224.06
1184.17
1200.82

RT (min)

W-Oct DGWO

W-IF DGWIF

IF-Oct DDGIFO

32.0
31.7
31.4
30.5
30.2
28.8

1.72
1.34
0.96
0.34
0.04
11.04

1.80
1.08
0.36
0.89
0.17
10.02

10.08
0.26
0.60
10.63
10.13
11.02

Peptide sequences: O represents ornithine, and d represents the D-enantiomer. Molecular mass: Calculated (c), and measured (m) molecular masses of
peptides, using electrospray mass spectrometry. MW is the molecular mass. Molecular masses are measured as [M1H]1. Retention times: (RT) on the RPHPLC C4 column. Solvents A (water 1 0.05% TFA) and B (acetonitrile 1 0.05% TFA) were used at a ﬂow rate of l mL/min with a gradient from 100%
A /100% B in 50 min. Hydrophobicity: Relative free energy of transfer of the peptides from water to octanol (DGWO), water to POPC bilayer interface
(DGWIF), and the difference between the two (DDGIFO) were calculated on the basis of whole-residue hydrophobicity scales (16). The free energy of transfer
of peptide bonds to octanol and the effect of the peptide backbone structure, which are comparable for all peptides, were not considered in these calculations.
Note that W stands for water; Oct stands for octanol; IF stands for interfacial; and IF-Oct stands for interfacial to octanol; free energies are in kcal/mol.
Biophysical Journal 95(7) 3306–3321
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in buffer (Tris, 10 mM and NaCl, 100 mM, at pH 7.4) were injected in 3–20
mL aliquots to the peptide buffer solutions (20–40 mM; reaction cell volume ¼
1.4352 mL). In the models employed for the analysis of ITC data, we have
assumed that the peptides interact with the outer leaﬂets of vesicles and
therefore, on the basis of geometric parameters for large unilamellar vesicles,
an estimated 50% of the total lipid concentration was used in all calculations.
Control and baseline adjustment experiments were performed in both vesicle
systems by injecting vesicles in buffer in the absence of peptides. The incremental enthalpies (heat ﬂow per injection) were corrected by subtracting
the reference baselines from the measured values. Peptides were fully titrated
with lipids until no change in the baseline proﬁle was observed. Binding
isotherms of the peptides with both lipid systems were derived and surface
binding (partitioning) models were utilized for data analysis.

RESULTS
Antimicrobial and hemolytic activities of the
cyclic peptides
Cyclic peptides of this study are listed in Table 1 in order of
their retention times, on a reversed phase HPLC column.
These retention times correlate well with the whole-residue
scale for free energies of the transfer from water to octanol
(DGWO) and water to POPC interface (DGWIF), representing
the lipid bilayer hydrophobic interior and interface, respectively (16) (Table 1). GS10WW and GS10YY had the highest
and lowest retention times, respectively. Biological activities
of three peptides (GS, GS10YY, and GS10WW) are exhibited
in Tables 2 and 3. These peptides were all hemolytic (Table 2)
and their hemolytic activity (possible afﬁnity for hydrophobic
interaction with dominantly zwitterionic membrane of erythrocytes) was also in direct correlation to their retention times
(afﬁnity for the hydrophobic stationary phase of RP-HPLC
columns), DGWO and DGWIF values. GS10WW was the most
hemolytic peptide and had the highest retention time and
greatest overall hydrophobicity. These results are in agreement with the direct relation between the hemolytic activity
and hydrophobicity/amphipathicity (as measured by retention times on RP-HPLC) of other biologically active cyclic
cationic peptides ((5,13,14), and references therein). Activities against certain strains of the Gram-positive bacteria were
comparable for three peptides and GS had the most potent
activity (Table 2). Finally, compared to GS10WW, both GS

and GS10YY were more active against the tested Gramnegative bacteria (Table 3).
CD analysis of the cyclic peptide conformations
The far-ultraviolet (UV) CD spectra of cyclic peptides in
buffer and unilamellar phospholipid vesicles, supported by
other structural data and molecular modeling studies, suggested comparable conformations for all peptides. The CD
spectra for the six cyclic peptides in these milieus are exhibited in Fig. 2, A and B, respectively. Spectra of all peptides
had double-negative maxima in the range 203–208 nm and
215–220 nm. In comparison to the CD spectra in the buffer
system, in the POPC liposomes the overall shape of the
spectra were changed and the negative ellipticities of all
peptides were enhanced. The single positive maximum of the
spectra is not shown due to increased noise detected at
wavelengths ,190 nm in the 0.1 cm path-length cell. In other
measurements using a 0.05 cm path-length cell, the maxima
for the peptides were detected between 185 and 188 nm (data
not shown). Under the same conditions, the CD spectra of the
six cyclic peptides in the negatively-charged POPE/POPG
(7/3 molar ratio) unilamellar vesicle system, was comparable
to the CD spectra in POPC vesicles (spectra not shown).
Based on the structural data (NMR, x-ray diffraction, and
CD) for GS and GS10YY (9–11,14) a cyclic backbone
structure composed of an antiparallel b-sheet with two type II9
b-turns on both ends of the sheet has been assigned to these
peptides, an example of which is shown in Fig. 1.
The concentration-dependent CD spectra of GS (as the
representative of the cyclic peptides of this study) in neutrally
charged POPC vesicles (Fig. 3 A) did not change in the range
1:100 to 1:10 peptide/lipid molar ratios (P/L), indicating a
stable conformation with a positive maximum at 186 nm and
two negative maxima at 206 and 218 nm. The negative
maximum at 218 nm was shoulderlike at low P/L ratios (inset
in Fig. 3 A). In contrast to the spectra in phosphatidylcholine
(PC) vesicles, the concentration-dependent spectra of GS in
the negatively-charged PE/PG vesicles (Fig. 3 B) indicated a
decrease in ellipticity as the P/L ratio increased from 1:100 to
1:10. Increase in the P/L ratio in the PE/PG system resulted in

TABLE 2 Biological activity of peptides against human erythrocytes, Gram-positive bacteria, and yeast after 24 h at 37°C
Minimal inhibitory concentration (mg/mL)*
yz

Peptide
GS
GS10YY
GS10WW

Hemolytic
(mg/mL)
12.5
25
3.1

S. aureus
SAP0017

S. aureus
K147

S. epidermidis

B. subtilis

E. faecalis

C. xerosis

Geometric mean
Gram-positive§

C. albicans

1.5
6.2
1.5

1.5
6.2
3.1

1.5
4.5
1.5

3.1
6.2
3.1

1.5
3.1
1.5

1.5
1.5
1.5

1.7
4.1
1.9

4.0
6.2
6.2

A minimum of three experiments was performed for each biological activity assay.
*Activity against Gram-positive bacteria was measured in liquid broth assays as described previously ((14) and references therein).
y
Freshly collected human blood cells were prepared and hemolytic liquid-based assays were performed as described previously (12,14).
z
Concentrations for hemolytic activity were the minimum required for complete lysis of erythrocytes.pﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Q
§
Mean MIC values (after 24 h) against Gram-positive bacteria. Geometric mean for n numbers: â ¼ n ni¼1 ai ¼ ða1 3a2 . . . : : an Þð1=nÞ :
Biophysical Journal 95(7) 3306–3321

Cyclic Peptide-Membrane Interaction

3309

TABLE 3 Biological activity of peptides against Gram-negative bacteria after 24 h at 37°C
Minimal inhibitory concentration (mg/ml)*
Peptide
GS
GS10YY
GS10WW

y

P. aeruginosa
K799 (H187)

P. aeruginosa
Z61(H188)

E. coli
UB1005

E. coliy
DC2

S. typhimurium
C587

S. typhimuriumy
C610

Geometric mean
Gram-negativez

25
50
100

6.2
6.2
12.5

9.0
25
50

3.1
6.2
6.2

18
200
200

9.0
25
200

5.6
9.9
24.9

A minimum of three experiments was performed for each biological activity assay. For the deﬁnition of geometric mean, please see footnote§ in Table 2.
*Activity against Gram-negative bacteria was measured in liquid broth assays as described previously ((14) and references therein).
y
Supersusceptible derivatives of Gram-negative bacteria with more permeable outer membranes.
z
Mean MIC values (after 24 h) against supersusceptible Gram-negative bacteria, P. aeruginosa Z61, E. coli DC2, and S. typhimurium C610.

a gradual change of the GS spectrum accompanied by a decrease in the ellipticity ratio (u206/u218) and an overall red
shift of the negative maxima.
Use of ﬂuorescence resonance energy transfer
(FRET) in determining the longer dimension of
the cyclic peptides
All of the peptides listed in Table 1 contain one or two types of
aromatic amino-acid residues (intrinsic ﬂuorophores: F, W,
Y) in their structure. Tryptophan has the highest absorptivity
and emission intensity and is the most sensitive of the three
aromatic residues (F, W, Y) in that its emission maximum
wavelength, in comparison to the aqueous solvents, has a
conspicuous blue shift and relative increase in intensity in
hydrophobic environments (17,18). In this study, we used the
emission spectra of aromatic amino acids to characterize the
interaction of the peptides with lipid bilayers and to estimate
the distance between the two ends (two aromatic residues) of
the peptides in different milieus. An example of emission
spectra proﬁle of Trp-containing cyclic peptides is exhibited
in Fig. 4. The maxima of the emission (excitation at 280 nm)
of GS10WY in buffer, 80% methanol, and PC vesicles are at
353, 343, and 342 nm, respectively. The intensity of emission
increased in the same order from buffer to more hydrophobic

milieus. Tryptophan ﬂuorescence was dominant in these
peptides and obscured the contribution of tyrosine or phenylalanine emission. Tryptophan normally displays emission
maximum of ;350 nm in aqueous environment and the
emission maximum shifts to lower wavelengths in less polar
hydrophobic solvents. Phenylalanine does not contribute to
emission at the corresponding excitation wavelength at 280
nm. Excited at 280 nm, Trp-lacking, Tyr-containing peptides
GS10YY and GS10FY had an emission maximum at 302–
303 nm in buffer and 80% methanol (higher intensity in
methanol) and the emission spectra of these peptides in PC
vesicles had a maximum at 306 nm. All these emission
maxima corresponded to tyrosine emission. The Phe-containing peptide GS did not emit at 280-nm excitation.
Resonance energy transfer between Tyr and Trp in GS10WY
was utilized to estimate the distance between the ﬂuorophores
(17–19). This distance corresponds to the longer dimension
(length) of the cyclic peptide estimated by measuring the
distance between the Ca carbons of the D-Phe residues (or any
two aromatic residues) located symmetrically in the peptide
molecule (Fig. 1 and Fig. 5 A).
Tyrosine in GS10WY was the donor (D) and tryptophan
was the acceptor (A) of Tyr energy. To complete the calculations for the efﬁciency of the energy transfer and the Förster
distance of the Tyr-Trp pair in GS10WY, the spectroscopic

FIGURE 2 CD spectra of the six peptides in Tris
buffer (A), and POPC vesicles in Tris buffer (B). See
Instrumentation for experimental conditions.

Biophysical Journal 95(7) 3306–3321
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FIGURE 3 CD concentration-dependence spectra of GS in POPC (A), and POPE/POPG (B)
vesicles dispersed in Tris buffer. See Instrumentation for experimental conditions.

properties of two other conformationally equivalent peptides
in the series, GS10FY (the donor-only peptide) and GS10FW
(the acceptor-only peptide) were also determined. At the
excitation wavelengths used for measurements (280 and 295
nm), the energy transfer between FY and FW ﬂuorophore
pairs in the latter peptides is minimal and not detectable.
Förster distance, R0, is the donor-acceptor distance at 50%
FRET efﬁciency and measured by the equation (17)
Z
9000ðln10Þk2 QD N
6
4
FD ðlÞeA ðlÞl dl
R0 ¼
5
4
128p Nn
0
2
9000ðln10Þk QD
¼
JðlÞ:
(1)
128p5 Nn4
In the above equation, FD (l) is the corrected ﬂuorescence
intensity of the donor (area under the curve in the l to l 1 Dl

range normalized to unity); QD is the quantum yield of the
donor in the absence of acceptor; eA(l) is the molar extinction
coefﬁcient of the acceptor; n is the refractive index in aqueous solutions (1.33–1.4 for biomolecules (19), n ¼1.35 in
these calculations); N is the Avogadro number; and 0 # k2 #
4 is a term denoting the relative orientations of the donor and
acceptor transition dipoles in space. Assuming the free rotations of donor and acceptor ﬂuorophores in space, k2 is
normally considered to be equal to 2/3, which is an appropriate average value for the calculation of R0 without a signiﬁcant error unless k2 reaches
R Nzero (perpendicular transition
dipoles) (17). The integral 0 FD ðlÞeA ðlÞl4 dl in Eq. 1 is
equivalent to the term J(l), which is the overlap integral
between the emission of the donor (Tyr) and absorption of the
acceptor (Trp). Considering the known experimental values
and constants, Eq. 1 can be simpliﬁed as
2 4

R0 ¼ 0:211ðk n QD JðlÞÞ :
1=6

(2)
1

In the above equations, l and J(l) are in nm and M cm1
(nm)4 units, respectively. Förster distance thus calculated is
in Å units. The overlap integral J(l) or JDA (DA stands for
donor-acceptor) was determined experimentally by calculating the area under the overlap spectrum between the corrected
and normalized emission of GS10FY (the donor without acceptor construct) and the absorption of GS10FW (the acceptor without donor construct) spectra. The overlap integral JDA
can be replaced for J(l) in Eq.2 to cover the whole range of
overlap wavelengths:
R0 ¼ 0:211ðk2 n4 QD JDA Þ :
1=6

FIGURE 4 Emission spectra (excitation at 280 nm) of GS10WY in Tris
buffer, 80% methanol, and POPC vesicles dispersed in Tris buffer. See
Instrumentation for experimental conditions.
Biophysical Journal 95(7) 3306–3321

(3)

The relative quantum yield of the donor ﬂuorophore (QD) in
GS10FY construct is calculated by the following equation:


IP AA
:
(4)
QD ¼ QA
IA A P
In this equation QA is the quantum yield of the standard
amino acid (0.14 for Tyr in water) (20); IP and IA are
integrated emission (ﬂuorescence intensity) for the peptide
and standard amino acid, respectively; and AP and AA are the
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6

R
E ¼ 6 0 6;
R0 1 r

FIGURE 5 Top views of molecular models of GS: top view of the GS in
Fig. 1 with omitted amino-acid side chains (A), and top view of GS bound to
a bacterial proteinase (22) (only GS is shown) (B).

maximum absorption (optical density at ;280 nm) for the
peptide and standard amino acid, respectively. The QD values
for the donor peptide, GS10FY, are shown in Table 4. These
values correspond to the range of Tyr quantum yields (0.03–
0.05) observed in proteins (19). Since the absorption spectrum was not attainable for the peptide in POPC vesicles due
to high scattering, assuming that the peptide is located at the
interface of lipid membranes, the average value of the absorption of peptide in buffer and 80% methanol was taken for
AP in POPC vesicles.
The energy transfer efﬁciencies (E) in the last column in
Table 4 were experimentally determined on the basis of
E¼1

FDA
:
FD

(5)

FDA and FD are the ﬂuorescence intensities of the donor in the
presence and absence of the acceptor, respectively. The E and
R0 values in Table 4 were used to calculate the distance
between Tyr and Trp (r) in GS10WY in three different
environments (buffer, 80% methanol, and POPC vesicles)
(Table 4) employing

r ¼ R0

1E
E

1=6
:

(6)

The r values are in the range of 0.63R0 to 1.24R0, which is
acceptable for FRET-based estimations of molecular distances (0.5–2R0 range). In comparison with the r value in
buffers, the r values in 80% methanol and POPC vesicles
were increased 75% and 85%, respectively (Table 4). The DA
(r) distance derived for the peptide molecules in 80% methanol and PC vesicles (12.6 and 13.3 Å, respectively) was in a
good correspondence with the distance shown for the longer
dimension of the extended peptide conformation in Fig. 5 A
(13.2 Å: distance between the Ca carbons of the aromatic
residues), the crystal structure of the bis-Boc-tetra-n-methyl
derivative of GS (12.8 Å) (21), as well as the longer dimension of the high resolution crystal structure of GS bound
to the active domain of a bacterial Subtilisin saviase proteinase molecule shown in Fig. 5 B (13.9 Å) (note that the
crystal structure of a complex formed between alkaline
proteinase savinase and gramicidin S at 1.5 Å resolution
has been deposited at the Protein Data Bank under PDB ID:
1tk2 (22)).

ITC measurements
Amphipathic cyclic peptides of this study have comparable
conformations and overall charge (12), therefore, application of surface binding (partitioning) models can provide an
appropriate relative scale to evaluate the thermodynamics of
peptide-lipid interactions. For this purpose, binding isotherms of peptide-lipid interactions were determined by
calorimetric measurements of titration of lipid dispersions
into peptide solutions. On the basis of these binding isotherms, it was assumed that peptide molecules bind to the
surface and partly partition into the interior of lipid bilayers.
Representative isothermal calorimetric data for the titration of lipids into peptide solutions are exhibited in Fig. 6 (in
POPC vesicles) and Fig. 7 (in POPE/POPG vesicles). These
data represent all examples of the binding proﬁles observed
for the cyclic peptide series of Table 1. Fig. 6 A exhibits the
heat ﬂow proﬁle of the titration of PC vesicles into GS solutions (top), as well as the total heat per injection at different
lipid/peptide molar ratios (bottom). At the initial peptide and
lipid concentrations (5 mL aliquots of 5 mM lipid vesicles
were injected into 20 mM peptide solutions), the binding of

TABLE 4 FRET parameters for the decameric cyclic cationic peptide GS10WY at 25°C
Environment
Buffer
80% Methanol
POPC vesicles

QD

JDA (M1 cm1 nm4)

R0 (Å)

r (Å)

FRET efﬁciency

0.039
0.027
0.033

3.034 3 10
4.067 3 1012
2.072 3 1012

11.4
11.2
10.7

7.2
12.6
13.3

0.94
0.33
0.21

12

For description and calculation of parameters, see the Materials and Methods and Results sections. Peptide concentrations for FRET measurements were 10
mM. The P/L ratio for the cyclic peptides in POPC lipid dispersions was 1:100; at this ratio, all peptides were bound to vesicles, as veriﬁed by CD
concentration-dependent experiments (e.g., Fig. 3 A).
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FIGURE 6 Heat of binding of peptides to POPC vesicles: GS (A), GS10WW (B), and GS10FY (C). See Instrumentation for experimental conditions. The
‘‘molar ratios’’ in the ﬁgures are lipid/peptide molar ratios.

GS to PC vesicles was endothermic and resolved into two
components as shown in the inset of Fig. 6 A. In contrast,
binding of the Trp-containing peptide GS10WW to PC vesicles was exothermic with no clear resolution into components, as exhibited in Fig. 6 B. The heat ﬂow proﬁle of the
binding of the rest of the cyclic peptides to PC vesicles was
endothermic (GS10YY, GS10FW, and GS10FY) or exothermic (GS10WY). Partial resolution of the single injection heat
ﬂow was also observed in other peptides such as GS10FY
(Fig. 6 C). Total heat per injection versus lipid/peptide molar
ratio graphs are shown in the inset of Fig. 6, B and C.
The binding of GS to PE/PG vesicles was also endothermic but not clearly resolved into two components (Fig. 7 A).
Another unique feature in this heat ﬂow proﬁle of GS in the
PE/PG lipid system (not observed in other cyclic peptides
under similar conditions) is the appearance of a chaotic pattern after the 9th injection of lipids. The heat ﬂow diminished
to baseline at L/P $ 14. The data points between 9th and 14th
injections were not included in the curve-ﬁtting for calculating the thermodynamic parameters to exclude the processes that could be related to vesicle fusion and other
nonspeciﬁc interactions, therefore unrelated to peptide
binding (Fig. 7 A, inset). We have repeated this experiment
several times with independent preparations and observed
Biophysical Journal 95(7) 3306–3321

similar heat ﬂow patterns. Binding of the rest of cyclic peptides to PE/PG vesicles was also endothermic as exhibited in
Fig. 7, B and C, for GS10WW and GS10FY, respectively.
Total heat per injection versus L/P molar ratio graphs are
shown in the inset of Fig. 7, B and C.
The total molar enthalpy of binding of peptides to lipid
systems (DHb) was calculated as DHb ¼ +i dhbi =ðCp Vcell Þ;
where dhbi is the heat of binding for injection i, Cp is the total
peptide molar concentration, and Vcell is the volume of the
sample cell of calorimeter. The experimental values for dhbi
and DHb (Table 5) were used to calculate the binding isotherms (23,24). The ratio of the heat of binding of the ﬁrst
injection to the total enthalpy of binding (dhb1 /DHb) suggested a range for the amount of peptide bound to lipids. For
example, in the ﬁrst lipid injection, close to 25% of the total
GS and 16% of the total GS10WW were bound to both lipid
systems, whereas 15 and 10% of GS10FY was bound to PC
and PE/PG lipids, respectively.
Binding isotherms for the interaction of three peptides
(GS, GS10WW, and GS10FY) with two lipid systems are
exhibited in Fig. 8. Each data point is derived from a single
injection of lipids into peptide solutions. Binding isotherms
were also obtained for the rest of the cyclic peptides. In Fig. 8,
Xb represents the degree of peptide binding deﬁned as the

Cyclic Peptide-Membrane Interaction

3313

cyclic peptides (Fig. 8) suggest that the relation between Xb
and Cpf is not linear and Keq (an apparent partition equilibrium constant independent of peptide concentration: Xb ¼
KeqCpf ) varies with the peptide concentration. The Keq for
GS in the PC lipid system varies between 3.7 3 104 M1 (Cpf ¼
15.1 mM) and 2.5 3 105 M1(Cpf ¼ 1.7 mM). The values of
Keq for the cyclic peptides, in a broad range of free peptide
concentrations, are tabulated in Table 5. To calculate the
binding constants for the cyclic peptides to the lipid systems
under equilibrium conditions, we have applied simple oneand two-site binding models to the binding isotherms, using
the equations
Kb Cpf
ðone-site bindingÞ;
(7)
Xb ¼ Bmax
1 1 Kb Cpf
Kb1 Cpf
Xb ¼ Bmax1
1 1 Kb1 Cpf
Kb2 Cpf
1 Bmax2
ðtwo-site bindingÞ:
(8)
1 1 Kb2 Cpf
In these equations, the Bmax, Bmax1, and Bmax2 are the
maximum binding capacity (in mol/mol) of the peptides to lipid
vesicles, and Kb, Kb1, and Kb2 are the equilibrium binding
(surface partitioning) constants. One- and two-site models
were ﬁt to the data by Levenberg-Marquardt nonlinear leastsquare algorithms to obtain the values for the Bmax and Kb.
Calculation of Kb values resulted in the calculation of free
energies of binding (DGb) of peptides using the equation
DGb ¼ RTlnð55:5Kb Þ:

FIGURE 7 Heat of binding of peptides to POPE/POPG vesicles: GS (A),
GS10WW (B), and GS10FY (C). See Instrumentation for experimental
conditions. The ‘‘molar ratios’’ in the ﬁgures are lipid/peptide molar ratios.

moles of peptide bound per moles of lipid (Xb ¼ npb/nl), and
Cpf is the concentration of free peptide in solution. An
equilibrium condition is assumed in the binding of peptides
to lipid vesicles and on the basis of this assumption and the
binding isotherms, Xb is a function of the free peptide concentration: Xb ¼ f(Cpf). The binding isotherms derived for the

(9)

In this equation, R is the universal molar gas constant and T is
the absolute temperature. The factor 55.5 is the molar
concentration of water and in this way the cratic contribution
to the free energy (;2.4 kcal/mol at 30°C) is taken into
consideration (25). Finally, entropy of binding (DSb) was
calculated as DSb ¼ (DHbDGb)/T.
Table 5 provides a relative scale for comparison of the
thermodynamic parameters of peptide-lipid interactions. The
one-site binding (partitioning) model was only used for
the exothermic interactions of GS10WW and GS10WY with
PC vesicles. Two-site binding (partitioning) model was used
for all other endothermic peptide-lipid interactions. In the
two-site models, the thermodynamic parameters were resolved for each binding event. Both binding models had
excellent ﬁts to the binding isotherms as is shown by simulations (solid lines) in Fig. 8.
The DHb values were variable in different peptides. In the
PC lipid system, DHb was small and positive (endothermic
interaction) for GS, GS10YY, GS10FW, and GS10FY, and
negative (exothermic interaction) for GS10WW and GS10WY
(Table 5). In the PE/PG lipid system, DHb was positive
(endothermic interaction) for all six peptides, and had higher
values in comparison to the PC system (Table 5). In the twostep binding processes, the ﬁrst binding constant (Kb1) was
102103 times larger than the second binding constant (Kb2),
Biophysical Journal 95(7) 3306–3321

3314

Jelokhani-Niaraki et al.

TABLE 5 Thermodynamic parameters of the peptide-lipid interactions

Peptide
GS
PC

DHb 3 103
(total)
(cal.mol1)
1.3

PE/PG

5.2

GS10YY
PC

0.9

PE/PG
GS10WW
PC
PE/PG
GS10FW
PC

5.1

2.5
2.2

0.25

PE/PG

4.2

GS10WY
PC

1.5

PE/PG

3.8

GS10FY
PC

0.9

PE/PG

7.4

Keq (M1)

DHb 3 10
(cal.mol1)

3

Bmax
(mol/mol)

Kb (M1)

DGb 3 10
(cal.mol1)

DGb 3 103
(total)
(cal.mol1)

Keq
Keq
Keq
Keq

(15.1 mM) 3.7 3 104
(1.7 mM) 2.5 3 105
(15.6 mM) 3.2 3 104
(1.1 mM) 3.2 3 105

Bmax1
Bmax2
Bmax1
Bmax2

0.36
0.35
0.29
0.26

Keq
Keq
Keq
Keq

(22.4 mM) 2.2 3 104
(4.2 mM) 7.9 3 104
(16.5 mM) 1.0 3 104
(0.6 mM) 2.0 3 105

Bmax1
Bmax2
Bmax1
Bmax2

0.27
0.36
0.11
0.13

Keq
Keq
Keq
Keq

(16.7 mM) 3.7 3 104
(1.0 mM) 2.2 3 105
(16.7 mM) 2.3 3 104
(1.2mM) 2.4 3 105

Bmax 0.74

Kb 3.2 3 105

DHb 2.5

DSb 24.9

DGb 10.0

10.0

Bmax1 0.26
Bmax2 0.16

Kb1 6.9 3 107
Kb2 4.2 3 105

DHb1 1.5
DHb2 0.7

DSb1 48.6
DSb2 36.1

DGb1 13.2
DGb2 10.2

12.2

Keq
Keq
Keq
Keq

(25.7 mM) 6.4 3 104
(3.1 mM) 3.3 3 105
(15.8 mM) 1.5 3 104
(1.3mM) 1.0 3 105

Bmax1
Bmax2
Bmax1
Bmax2

Kb1 108
Kb2 8.3 3 104
Kb1 5.3 3 108
Kb2 1.4 3 105

DHb1
DHb2
DHb1
DHb2

DSb1
DSb2
DSb1
DSb2

DGb1
DGb2
DGb1
DGb2

11.9

Keq
Keq
Keq
Keq

(16.6 mM) 2.4 3 104
(1.7 mM) 7.6 3 104
(17.7 mM) 1.5 3 104
(1.1mM) 1.8 3 105

Bmax 0.70

Kb 8.7 3 104

DHb 1.5

DSb 25.4

DGb 9.2

Bmax1 0.17
Bmax2 0.12

Kb1 2.9 3 108
Kb2 2.2 3 105

DHb1 2.7
DHb2 1.1

DSb1 55.2
DSb2 36.0

DGb1 14.0
DGb2 9.8

12.8

Keq
Keq
Keq
Keq

(34.1 mM) 2.0 3 104
(1.3 mM) 3.0 3 105
(18.2 mM) 1.1 3 104
(1.2 mM) 1.0 3 105

Bmax1
Bmax2
Bmax1
Bmax2

Kb1
Kb2
Kb1
Kb2

DHb1
DHb2
DHb1
DHb2

DSb1
DSb2
DSb1
DSb2

DGb1 13.3
DGb2 9.5
DGb1 14.8
DGb2 9.8

11.6

0.82
1.2
0.10
0.20

0.35
0.50
0.09
0.14

Kb1
Kb2
Kb1
Kb2

7.0
1.5
9.0
2.8

107
105
108
105

DHb1
DHb2
DHb1
DHb2

0.9
0.4
3.4
1.8

DSb1
DSb2
DSb1
DSb2

46.7
32.8
60.0
38.8

DGb1
DGb2
DGb1
DGb2

13.3
9.5
14.8
9.9

12.1

DHb1
DHb2
DHb1
DHb2

0.6
0.3
4.1
1.0

DSb1
DSb2
DSb1
DSb2

46.5
30.5
60.1
34.9

DGb1
DGb2
DGb1
DGb2

13.5
9.2
14.2
9.6

12.1

Kb2
Kb1
Kb2

Kb1 108
8.5 3 104
4.0 3 108
1.5 3 105

8.7
1.3
1.1
2.3

3
3
3
3

DSb
(cal.mol1.K1)

3

3
3
3
3

108
105
109
105

0.15
0.1
2.3
1.9

0.5
0.4
4.0
3.4

44.9
30.7
55.3
37.7

50.3
32.6
62.1
43.5

13.5
9.5
14.5
9.5

13.1

13.3

12.2

9.2

12.5

The reported data are the average of 2–4 independent measurements. See the Results and Discussion sections for details of one- and two-site binding models.
In ITC experiments, all peptides were in the sample cell and titrated with 3–5 mL of 5 mM lipid dispersions per single injection. In POPC titrations, GS10YY,
GS10FW, and GS10FY were at 40 mM concentrations; peptide concentrations in all other titrations with lipid dispersions were 20 mM.

which suggested a much higher afﬁnity for the ﬁrst step of the
binding process. In the two-step processes, DGb1 in PC and
PE/PG systems were comparable and in the range of 13.2 to
14.8 kcal/mol. In the same processes, DGb2 in PC and PE/
PG systems were in the range of 9.2 to 10.2 kcal/mol. The
latter free energies, as well as the Kb2 values, were comparable to the corresponding parameters, DGb and Kb, in the
one-step binding processes (GS10WW and GS10WY binding to PC). In the two-step processes, both DSb1 and DSb2 in
PE/PG systems were larger than their corresponding values
in PC. In the one-step binding processes, DSb of GS10WW
and GS10WY to PC were ,DSb2 in the two-step binding
processes (Table 5). Overall free energies of binding of the
peptides to the two lipid systems are reported in the last
column of Table 5. These values are calculated on the basis of
the contribution of enthalpy of binding, which is proportional
to the moles of bound peptide, to each binding process.
Compared with the PC system, the total DGb of peptides are
slightly lower in the PE/PG system. The lowest free energies
of binding in the PC system are those of GS10WW and
Biophysical Journal 95(7) 3306–3321

GS10WY (2–3 kcal/mol less than other peptides), which
participate in the one-site binding process. The total DGb of
peptides in the PE/PG system are comparable (12.2 to
13.1 kcal/mol). Total DGb of GS for binding to POPC
(12.1 kcal/mol at 30°C) is lower in comparison with the
previously reported DGb for GS (11.0 kcal/mol at 25°C) (26).

DISCUSSION
Conformation of the cyclic peptides
All decameric cyclic cationic peptides of this study (Table 1)
share common structural features and their difference is in
their aromatic amino acids (Fig. 1 and Fig. 5 A). The difference in retention times of peptides could be attributed to
the difference in the hydrophobicity of aromatic amino acids
with Trp being the most and Tyr the least hydrophobic amino
acids (16,27). Equivalent b-sheet-b-turn backbone conformations of the cyclic cationic peptides can be further veriﬁed
by comparing their CD spectra in aqueous and lipid vesicles.

Cyclic Peptide-Membrane Interaction

FIGURE 8 Binding isotherms for GS, GS10WW and GS10FY in POPC
(solid symbols) and POPE/POPG (open symbols) lipid systems.

The difference in the shape and ellipticities of these spectra
can be attributed to the differences in their aromatic aminoacid composition—Trp and Tyr can interfere with the CD
spectra of the backbone conformation in the 225–240 nm
range—and their tendencies to interact with lipid vesicles. In
the last column in Table 1, DDGIFO values can be used to
estimate the tendencies of the peptides to interact with the
hydrophobic core versus the interface of POPC bilayers. In
this scale, GS and GS10YY have the highest tendency to
interact with the bilayer core and bilayer interface, respectively. GS10WW has a comparable afﬁnity for both environments. Other peptides with different aromatic residues are
located in between GS and GS10YY. Different tendencies of
peptide aromatic side chains to interact with different regions
of POPC bilayers could therefore inﬂuence their CD spectra.
The common feature of the CD spectra of cyclic peptides in
lipid vesicles was their substantial enhancement of negative
ellipticity in comparison to the spectra in buffer. The enhancement of ellipticity in lipid vesicles suggests strong interactions of these peptides with lipid vesicle surfaces as well
as their limited conformational change in the lipid environments. Moreover, the similarity of CD spectra of cyclic cationic peptides in zwitterionic and negatively-charged vesicles
implies that despite the role of electrostatic interaction in
attracting peptides to the surface of membranes, hydrophobic
interaction is the main factor in stabilizing the relatively inﬂexible structures of peptides in lipid membranes (28).
The conformation of GS is comparable and stable at different P/L ratios in PC vesicles; however, at higher P/L ratios
(1:15 and 1:10), the negative maximum at 218 nm was more
pronounced and replaced a shoulderlike negative maximum
at lower P/L ratios (Fig. 3 A and inset). The enhancement of
ellipticity at this negative maximum can be attributed to a
conformational change caused by intermolecular interactions
of peptides and/or peptides with lipids. Conversely, the
concentration-dependent spectra of GS in the negatively-
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charged PE/PG vesicles (Fig. 3 B) indicated a decrease in
ellipticity as the P/L ratio increased from 1:100 to 1:10. Increase in the P/L ratio in the PE/PG system resulted in a
gradual change of the GS spectrum accompanied by a decrease in the ratio of the negative maxima from 1.2 (u206/u218)
in the 1:100 to 1 (u208/u220) in the 1:10 P/L ratios. The shift in
the shape of CD spectra in the PE/PG system implies a conformational change that can be caused by peptide association
and/or speciﬁc electrostatic interaction between the cationic
peptides and anionic lipids at lower P/L ratios (5). The change
in the CD spectra at higher L/P ratios in the PE/PG system
can be also attributed to the change of optical properties of the
peptide/vesicle dispersion caused by the appearance of larger
fused vesicles induced by higher peptide concentrations ((5),
and M. Jelokhani-Niaraki, unpublished results).
The comparative ﬂuorescence spectra of cyclic peptides in
buffer, 80% methanol, and PC vesicles (Fig. 4) support the
CD data in conﬁrming the interaction of the cyclic peptides
with membranes. Three conformationally equivalent cyclic
peptides of the series (GS10WY (donor-acceptor), GS10FY
(donor-only), and GS10FW (acceptor-only)) (Fig. 2) were
employed to estimate the longer dimension of the cyclic
peptides (17,29). Table 4 exhibits the main parameters obtained from the FRET experiments. Förster distances were
between 10.7 and 11.4 Å for GS10WY. FRET efﬁciency was
the highest for the peptide in Tris buffer (0.94) and lowest for
the peptide in the PC system, which directly corresponded to the
shortest (7.2 Å) and longest (13.3 Å) DA distances, respectively. The DA distance in 80% methanol (12.6 Å) is very
close to the DA distance in the PC vesicles. The DA distances
(r), in Table 4, suggest that the cyclic b-sheet-b-turn construct of peptides undergoes a conformational change from
aqueous environment to less polar alcoholic and lipid
membrane environments. As with the CD spectra of the
peptides, this conformational change was attributed to stabilization of the b-sheet-b-turn backbone structure in less
polar environments. Overall, from the results of ﬂuorescence
studies, interaction of the cyclic peptides with lipid membranes was further conﬁrmed. Consequently, we can assume
two main conformations for the b-sheet-b-turn peptide
constructs in aqueous and less polar milieus: a contracted tense
b-sheet-b-turn in aqueous environment (short interaromatic
distance, 7.2 Å, before interaction with lipid membrane
surface) and an expanded relaxed b-sheet-b-turn in alcoholic
and PC vesicles (long interaromatic distance, 12.6–13.3 Å,
after interaction with lipid membrane surface).
Thermodynamics of interaction of the cyclic
peptides with lipid membranes
The interactions of GS with different phospholipid systems
PC, PE/PG, and PC/PG (26,30) were endothermic. In comparison to the zwitterionic PC vesicles, interaction of the
peptides with the negatively-charged lipid vesicles, PE/PG
and PC/PG (Fig. 7 A and (30), respectively), was more enBiophysical Journal 95(7) 3306–3321
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dothermic. For example, the enthalpy of binding of GS in
binding to PE/PG vesicles was four times its enthalpy of
binding to PC vesicles (Table 5).
Under our experimental conditions, the heat ﬂow proﬁle for
the binding of GS to POPC lipid vesicles was resolved into
two components (Fig. 6 A and its inset). This phenomenon has
not been reported in a previous publication on the POPC
binding to GS using the ITC technique (26). The two-site
binding model used to analyze the binding isotherms of GS
(Fig. 8) suggests a consistent qualitative and quantitative interpretation for this experimental observation. The ﬁrst sharp
peak in the heat ﬂow proﬁle of GS can be related to the fast and
high afﬁnity binding of free GS peptides to the added peptidefree POPC vesicles (Kb1 ¼ 7 3 107 M1) (Table 5), whereas
the second peak exhibits slower processes that implies a
second binding (low afﬁnity, Kb2,Kb1/100) step involving
further peptide-lipid and peptide-peptide interactions. As an
interpretation, in a two-step binding (partitioning) process,
initially a population of peptides binds to free lipid vesicles
(fast, high afﬁnity), and then a second population of peptides
binds to these peptide-bound vesicles (slow, low afﬁnity).
Binding of the ﬁrst population of positively-charged peptides
generates a positive charge density and membrane potential
on the lipid vesicle surface, and therefore reduces the binding
afﬁnity of the second population of peptides for the membrane
surface. Both partitioning steps, particularly the second step,
may also involve other exothermic or endothermic interactions such as peptide association processes, penetration of
hydrophobic regions of peptides into the bilayer hydrophobic
core, and rearrangement (association/dissociation) of water
molecules caused by the increase in the peptide concentration
at the bilayer surface and disruption of bilayer surface. It is
noteworthy to mention that concentration-dependent CD and
UV measurements of GS in POPC vesicles excluded vesicle
fusion (Fig. 3 A and M. Jelokhani-Niaraki, unpublished results) and its possible contribution to the endothermic process
in the second binding step. In both binding steps, hydrophobic
effects are the main binding driving force as supported by
large positive entropy values (DSb1 ¼ 46.7 and DSb2 ¼ 32.8
cal/mol.K). A two-step binding model was also applied to the
binding isotherm of GS in the PE/PG system and the thermodynamic parameters were resolved (higher Kb values,
Table 5). It is worth noting that we also applied a surface
binding (partition) model considering electrostatic effects to
the binding isotherms of GS and its aromatic analogs (24,31).
In this case, a two-site binding model was also applied to resolve the derived nonlinear binding isotherms. For both lipid
systems, membrane potential was always positive under our
experimental conditions and by considering the electrostatic
effects, the binding constants (in Table 5) were increased
accordingly (up to two orders of magnitude). These results
further supported the main role of hydrophobic effect in the
binding of GS and its aromatic analogs with lipid membranes.
Since there was no qualitative difference between the binding
isotherms in the two models, and the partitioning equilibrium
Biophysical Journal 95(7) 3306–3321
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constant (Kp) in the electrostatic model was not independent
of peptide concentration (24), we chose the above-mentioned
simple one- and two-site binding (partitioning) models (Eqs. 7
and 8) for the interpretation of our experimental data.
The two-site binding model proved to be the best experimental model for analysis of the endothermic interaction of
the cyclic peptides with both lipid systems employed in this
study. A two-step binding seemed to be obvious from some of
the heat ﬂow proﬁles of peptides in the PC lipid system.
However, in the PE/PG lipid system the single injection heat
ﬂow proﬁles were not clearly resolved. Applying the two-step
model has therefore revealed some of the subtleties of cyclic
peptide-lipid interactions, which were not otherwise observable in the heat ﬂow trends and have not been reported
previously. In the case of exothermic interactions of the two
Trp-containing peptides (GS10WW and GS10WY) with PC
vesicles, the single-step binding model gave the best ﬁt (Fig.
6 B, Table 5). This observation can be related to the strong afﬁnity of Trp for lipid vesicle membrane surfaces as well as its
high intrinsic hydrophobicity, which enhances the interaction
with the lipid vesicle hydrophobic core. A more detailed
analysis of the ITC data considering the afﬁnity of the aromatic amino acids for POPC bilayers using the whole-residue
hydrophobicity scales (16) may lead to a better understanding
of the interaction of GS and its conformationally equivalent
aromatic analogs with lipid bilayers. As exhibited in Table 1,
the calculated water-to-octanol relative free energies of partitioning of the peptides (DGWO), as a measure of their afﬁnity
for the bilayer hydrophobic interior, follow the order of their
retention times and the intrinsic hydrophilicity/hydrophobicity scale (27), with GS10WW and GS10YY being the most
and least hydrophobic peptides, respectively. The place of
GS10WY and GS is switched in water-to-interface partitioning relative free energies (DGWIF) of peptides. The
free energies of the transfer of peptides from bilayer interface
to bilayer hydrophobic core (DDGIFO) increase in the order of
GS.GS10FW.GS10WW.GS10FY.GS10WY.GS10YY.
By considering the DDGIFO values and the thermodynamic
parameters in Table 5, cyclic peptides can be categorized on
the basis of their afﬁnity for different regions of POPC bilayers—interface-water layers, polar headgroups, and hydrophobic interior. The DDGIFO values imply that GS has the
highest afﬁnity for the membrane core (DDGIFO ¼ 0.6 kcal/
mol), while GS10YY strongly prefers the membrane interface
(DDGIFO ¼ 11.02 kcal/mol). On the other hand, GS10WW
has an equal preference for membrane core and interface
(DDGIFO ¼ 10.08 kcal/mol). In this way, on the basis of the
relative afﬁnity of their aromatic residues for different regions
of the lipid bilayers, as shown in Fig. 9 A, the cyclic peptides
can be categorized into three groups: 1), peptides with more
afﬁnity for the bilayer hydrophobic core (GS); 2), peptides
with comparable afﬁnity for the bilayer core and interface
(GS10WW); and 3), peptides with more afﬁnity for the bilayer interface (GS10YY). Fig. 9 B, as well as Tables 1 and 5,
exhibit a direct relation between the total enthalpy of binding

Cyclic Peptide-Membrane Interaction

FIGURE 9 (A) Scheme for preferential binding of the cyclic aromatic
peptides to different regions of bilayer depending on their aromatic aminoacid composition (peptides have similar backbone structures); (B) comparison between the enthalpies and afﬁnities of binding of peptides to the
bilayer hydrophobic core versus bilayer interface (Tables 1 and 5).

(DHb) in each group of peptides and their DDGIFO. Single and
double substitutions of the F residues in GS to W or Y,
GS/GS10FW/GS10WW or GS/GS10FY/GS10YY,
result in the decrease in afﬁnity of peptide for the bilayer core
and DHb. Single and double substitutions of the Y residues in
GS10YY to W, GS10YY/GS10WY/GS10WW, result in
the decrease in afﬁnity for the bilayer interface and DHb. While
the dominant driving force for the binding of the cyclic peptides to bilayers seems to be the increase in the entropy of the
system through classical hydrophobic effect causing the exclusion of nonpolar surfaces from water, the contribution of
enthalpy to binding should not be underestimated. Contribution of enthalpy to the overall DGb of Trp-containing cyclic
peptides stresses the additional role of nonclassical hydrophobic effect in the interaction of these peptides with lipid
membranes. GS10WW and GS10WY have the least favorable entropy and the most favorable enthalpy of binding
among the cyclic peptides. Tryptophan has an afﬁnity for the
lipid bilayer surfaces in membrane-interacting proteins, and
the interactions of its indole derivatives with POPC membranes are exothermic; moreover, dipole interactions with the
bilayer polar headgroups and close van der Waals interactions
with the bilayer hydrophobic core may also contribute to the
exothermic interaction of Trp-containing cyclic peptides with
membranes (16). Phe-containing peptides GS and GS10FY
strongly interact with the bilayer hydrophobic core and have
higher positive entropies of binding. In addition to disruption
of the membrane surface water molecules, these peptides can
greatly disrupt the polar headgroups to reach bilayer interiors.
The Tyr-containing peptide GS10YY interacts mainly with
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the interface-water layers and bilayer polar headgroups and
seems to be the peptide with the least penetration into the
bilayer hydrophobic core. A schematic view of the interaction
of the cyclic peptides with different regions of the lipid bilayers is exhibited in Fig. 9 A. Overall, it seems that in these
peptides and similar constructs, changing the balance between the aromatic amino acids (for example, Phe versus Trp)
can modulate their mode of interaction with PC and PCcontaining (30) lipid systems.
As mentioned above, in comparison with the enthalpy
values for the PC lipid system, the enthalpy of binding in PE/
PG lipid system was noticeably more positive (less favorable) and the entropy of binding was generally increased
(more favorable) (Table 5). This difference can be caused by
the structure and degree of hydration of the membrane surfaces as well as the packing of the lipid headgroups and
surface charge density of the vesicle systems. In comparison
to PC lipids, pure PE lipids with one or two unsaturated
hydrocarbon chains form bilayers with an inherent negative
curvature and prefer to switch to the hexagonal HII phase.
Addition of 30% of a bilayer-forming lipid, such as PG, to PE
lipids stabilizes the bilayer form and reduces the tendency of
PE to form the hexagonal HII phase (32). PE lipids are also
less hydrated than PC lipids and therefore less energy is required to access the dehydrated surface of these lipids;
however, addition of PG lipids disrupts the PE packing, and
by increasing the water-accessible surface area and hydration
of the bilayer surface, causes an increase in the overall dehydration energy and positive enthalpy of binding (33).
These factors may count for the different proﬁle of peptidebinding to PE/PG vesicles compared to PC or PC/PG vesicles. Another notable feature of peptide-binding to PE/PG
vesicles was observed in the heat ﬂow proﬁle of GS (Fig.
7 A). In this proﬁle, the stepwise decreasing heat ﬂow of the
titration of GS with PE/PG vesicles was interrupted with a
chaotic pattern. The origin of this phenomenon could be the
inherent fusogenic properties of unsaturated PE lipids induced by GS. It is plausible that after the ﬁrst 8–9 titrations of
GS with PE/PG vesicles almost all of the positively charged
peptides were bound to the lipid vesicles and the negativelycharged PG lipids on the surface of vesicles were shielded
and neutralized (the total positive charge of the peptides in
the sample cell can be neutralized by addition of ;40 mL of
lipids). In further additions, free PE/PG vesicles did not experience any strong electrostatic repulsion or organized hydration repulsive force from the neutralized peptide-bound
vesicles in the sample cell and could therefore approach the
peptide-bound vesicles. At the same time the peptide-bound
vesicle surfaces were destabilized by both the increase in
surface tension and fusogenic properties of PE lipids. The
chaotic pattern observed in the titration of GS with PE/PG
vesicles could be therefore attributed to nonspeciﬁc vesicle
fusion and other nonspeciﬁc events. This interpretation was
supported by the concentration-dependent light scattering
UV absorption experiments at 600 nm (data not shown).
Biophysical Journal 95(7) 3306–3321
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The binding afﬁnities of cyclic peptides for lipid systems
can be also related to their biological activities (Tables 1–3
and 5). For interaction with POPC vesicles, a model of
erythrocyte membranes, the Kb, for GS10WW could be
compared to the Kb2 values of GS and GS10YY. Among
these peptides, GS10WW was the most hydrophobic and
hemolytic, and also had the highest Kb and DGWO value. In
the POPE/POPG system, a model for bacterial membranes,
there was a relation between the Kb2 values and their activity
against Gram-positive bacteria; the higher Kb2 values corresponded to higher antimicrobial activity. In the same lipid
system, activity against Gram-negative bacteria could be also
directly related to the Kb1 values—peptides with higher Kb1
were more potent against Gram-negative bacteria.
The total DGb for the interaction of the peptides with lipids
can be separated into different terms:
DGb ¼ DGe 1 DGh 1 DGn 1 DGc 1 DGl :
DGe is the free energy of electrostatic (includes charge and
dipole interactions) interactions; DGh is the contribution of
hydrophobic effect to binding (includes the dehydration and
rehydration of peptide and lipid molecules and rearrangement of water molecules close to peptide and bilayer surfaces); DGn is the free energy of the interaction of peptide
side chains with the nonpolar regions of the bilayer; DGc is
the free energy related to the conformational changes of
peptide upon interaction with membranes; and DGl is the free
energy related to lipid bilayer deformation and structural
change. Each component contributes to the total free energy
in a subtle way that cannot be easily quantiﬁed experimentally. DGe has the most contribution in the interaction of
peptides with the anionic PE/PG membranes and the interaction of Trp- and Tyr dipoles with bilayer headgroup dipoles
or charges. Of all terms contributing to the total DGb, DGh is
the main determinant in the entropy-driven binding of peptides to both lipid systems. DGn also contributes to the
binding of all peptides, especially the Trp- and Phe-containing peptides. DGc could be comparable for all peptides and
DGl contributes most in the binding of peptides such as GS
and GS10FW that perturb the membrane structure most (Fig.
9, A and B). The DGb values reported in this study included
all of the above-mentioned free energy components. The
binding energies of the cationic cyclic peptides (Table 1) to
lipid membranes (DGb ¼ DHb  TDSb) were all negative
(Table 5). The TDSb term was positive and much larger than
the DHb term, which implies that the binding of peptides to
lipid membranes were entropy-driven. Favorable contribution
to the TDSb term in the equation for the free energy of binding
can be attributed to the rearrangement of hydration water
molecules around the peptide and lipid bilayer surface caused
by the binding of peptides, the change of the conformation of
peptides (elongation), and the deformation and expansion of
lipid bilayers. Electrostatic interaction between the membrane surface and the peptide charge (12) or dipoles (including the aromatic Trp or Tyr side-chain dipoles), van der
Biophysical Journal 95(7) 3306–3321

Waals interaction of the peptide side chains with bilayer
hydrophobic cores, and the hydration of bilayer surfaces are
the favorable contributors to the DHb.
Mechanism of interaction of the cyclic cationic
peptides with biological membranes
Two general models have been proposed for the mechanism
of GS interaction with lipid bilayers. In one model, GS
strongly interacts with the outer surface of membranes, resides on the surface (34), and destabilizes the overall membrane structure through membrane-thinning effect (35) and
peptide-lipid interactions causing membrane lysis (36). In
this model, GS does not associate to form organized pores
(37) and only generates nonspeciﬁc leakage through perturbation of membrane structure. In the second model, GS
molecules associate to generate channels by forming supramolecular double-stranded spirals in membranes that can
transverse the bilayer. This model is based on the supramolecular crystal structures of GS complexes in aqueous and
organic solvents (38,39). Preliminary electrophysiological
data have been reported on the GS channel-like activity in the
lipid bilayers, but the published data did not represent stable
channels (40,41). Moreover, in these reports, the analysis of
conductance events was not conclusive and electrophysiological properties of the channels such as open-close analysis
and voltage-dependence were not characterized.
The two-state model for the action of antimicrobial peptides, proposed by Huang (37,42), is a physical model based
on elasticity theory of lipid membranes. In this model the
peptide has two different equilibrium states in binding to
membranes. At low P/L ratios, the peptide adsorbs on the
lipid headgroup area and, once the P/L ratios increase and
passes a threshold value P/L*, the peptide associates to form
a multi-pore state, transverse the membrane, and cause
leakage. The P/L* ratio is different for each peptide and each
lipid membrane system. In this model, the pore formation is
considered to be a spontaneous cooperative event (37).
However, when the two-state model was applied to a cyclic
cationic octadecapeptide (u-defensin), despite the experimental evidence for the existence of the adsorbed state, no
evidence for a pore-forming structure or vertical insertion of
this peptide was found (43).
Based on the experimental results of this study and our
previous studies (5), and by considering the concepts developed in the above-mentioned two general mechanistic
models, a qualitative model is suggested for the entropydriven interaction of GS and GS-like peptides with biological
membranes as outlined in Fig. 10. At the concentrations used
for this study, peptides are monomeric, and are in their tense
conformation in the aqueous environment (28). Initially,
peptides approach the bilayer surface in their tense conformations (short interaromatic length, 7.2 Å) (Fig. 10, step 0;
Fig. 2 A; and Table 4). In the next step (Fig. 10, step 1),
adsorption of peptide on lipid bilayer surface is accompanied
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by the rearrangement of water molecules on bilayer and
peptide surfaces (mostly an endothermic reaction, high Kb
and DSb; see Table 5). Electrostatic attractive forces between
the positively-charged peptide and membrane surface negative charges (in case of PE/PG bilayers) also contribute to and
enhance the adsorption of peptides (higher DHb and DSb
compared with PC bilayers; see Table 5). In the next stage
(Fig. 10, step 2), after initial interaction of peptides with bilayer surfaces, peptides expand their conformation from
tense to relaxed state (long interaromatic length, 13.3 Å)
(stabilization of intramolecular H-bonds, increase in DS) and
interact more favorably with the bilayer surface (Fig. 2 B,
Table 4). At this stage, the bilayer structure at the surface is
perturbed and the area of the bilayer surface expands in
proportion to the cross-sectional area of the peptide (e.g., the
cross-sectional area of GS, ;258 Å2 (44), roughly equals the
cross-sectional area of four PC lipid headgroups). Bilayer
surface expansion (increase in DS) results in the increase in
surface tension and thinning of the bilayer (37,45,46). Cyclic
peptides can compensate for this increase in the surface expansion by reducing their cross-sectional area (tilting or inversing their orientation) through deeper interaction with the
bilayer surface and hydrophobic regions.
At high concentrations, peptide interaction with membranes could result in further perturbation of bilayer structure
(increase in DS and hydrophobic interaction) and may lead to
generation of transient lipid-peptide zones of nonspeciﬁc size
in equilibrium with the surrounding environment, enhancing
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the leakage through membranes (Fig. 10, step 3). Concentration-dependent dye-leakage experiments with GS and
GS10YY, has been in support of this assumption (5). Our
experimental data in this study strongly support the ﬁrst
two stages of peptide interaction with membrane surfaces
(Fig. 10, steps 1 and 2). Further investigations are required
for experimental characterization of lipid-peptide porelike
zones. Finally, despite their transition from tense to relaxed
state upon interaction with bilayer surfaces, depending on
their aromatic amino-acid residue composition, cyclic aromatic peptides preferentially interact with different regions of
the bilayer and disrupt the membrane surface to different
degrees (Fig. 9 A). GS prefers to penetrate into the bilayer
hydrophobic interior, GS10WW prefers the bilayer interface,
and GS10YY interacts mostly with the polar headgroups of
the bilayer and penetrates least into the hydrophobic core.
Interestingly, a solid-state 19F-NMR study on the DMPC
membrane-bound structure of a 19F-labeled GS (L/P: 80:1
mol/mol), in which both leucine residues were replaced with
4F-phenylglycine, indicated that the backbone of the 19F-GS
analog lay ﬂat at the membrane surface, with its hydrophobic
face buried in the bilayer hydrophobic core and its hydrophilic face interacting with the bilayer polar headgroups (34).
The results of this structural study are therefore in agreement
with the scheme for GS in Fig. 9 A and the second stage (Fig.
10, step 2) of our proposed mechanism. Overall, the proposed
qualitative model (Fig. 10) considers the general modes of
interaction of all peptides with lipid bilayers, which includes

FIGURE 10 A mechanism for the binding of GS
and its aromatic analogs to lipid bilayers: (0) Monomeric cyclic peptides are attracted to and approach
the bilayer surface in their tense conformation. (1)
Cyclic peptides adsorb on the bilayer surface and
bind to surface through hydrophobic effect and
electrostatic interactions; tense conformation of cyclic peptides changes toward relaxed conformation.
(2) Cyclic peptides adopt the relaxed conformation,
insert deeper into bilayer, deform the membrane
structure without forming peptide-peptide associations, and induce leakage (low P/L ratios). (3)
Cyclic peptide-lipid complexes form nonspeciﬁc
transient porelike zones enhancing the leakage
through membranes (high P/L ratios).
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binding, conformational change, and disruption of membrane
interface and structure.
In conclusion, interaction with the phospholipid components of microbial membranes may not be the only mechanism for the biological activity of GS-like antimicrobial
peptides. The mechanism of biological activity of antimicrobial peptides can include speciﬁc inhibitory interactions
with the components of metabolic pathways (including
membrane protein receptors) and immune systems of organisms (1,47). By understanding the mechanism of interaction
of GS-like molecules with biological membranes and considering interactions of these cyclic peptides with other biomolecules, such as carbohydrates (48) and components of
metabolic pathways (49), a comprehensive picture of their
biological activity is anticipated in future.
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